updat price target
updat estim inovalon
price target unit
underweight rate increas ep estim
versu consensu ep estim
prior versu consensu chang
estim reflect combin termin low-margin
contract margin expans catalyst earn
guidanc see downsid risk revenu estim manag
continu evalu busi portfolio
equal-weight rate increas ep estim
prior versu consensu reflect cost cut
initi technolog invest result margin expans
see upsid risk estim acceler organ growth
price target previous repres
upsid last close price
price target previous repres upsid
last close price
price target previous repres upsid
last close price
price target previous repres upsid
last close price
price target previous repres
upsid last close price
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
democrat debat analyst day analyst
day possibl circuit decis
insid note lay summari price target chang estim
chang updat risk/reward bull/bear financi
summari price target chang
exhibit summari estim chang
exhibit bull/base/bear case valuat impli upside/downsid current stock price
updat price target four manag care compani reflect
rel valuat versu increas visibl earn provid
earn
price-to-earnings multipl expand mid-octob
manag care valuat framework base premiums/discount
 multipl refresh price target
addit earli guidanc provid unit
earn remov tx contract overhang provid
visibl see note
price target previous reflect expans
multipl last updat price target pt
repres upsid last close price base price-to-earnings multipl
appli base case ep base case multipl discount
current multipl bull/bear case valu
current multipl in-lin peak
compani see strong quarterli result yet get benefit
tax reform bear case multipl reflect turn discount
current multipl in-lin share trade
trough last price cycl
price target previous reflect expans
multipl last updat price target pt
repres upsid last close price base price-to-earnings multipl
appli base case ep base case multipl discount
current multipl bull/bear case valu
previous bull case multipl reflect turn discount
current multipl in-lin share trade
last elect year bear case multipl reflect turn discount
current multipl in-lin share trade
trough last price cycl
price target previous repres upsid last close
price base case multipl reflect turn discount
trade prior manag care sell updat
price target reflect move price-to-earnings multipl previous
current base case multipl expand
ep estim bull/bear case valu
previous bull case multipl reflect turn premium current
multipl in-lin stock trade peak
bear case multipl reflect turn discount current multipl
in-lin stock trade trough last
price target previous repres upsid last close
price price target base sotp valuat assign price-to-earnings
multipl benefit assumpt in-line averag
multipl rel prior medicar
sell current multipl trade modest
premium vs discount prior medicar sell sotp analysi still
assign ev/ebitda multipl retail reflect normal year
averag multipl ev/ebitda multipl pharmaci servic
reflect express script multipl one month prior acquisit announc
also continu model million net deal synergi million
price target previous reflect expans
multipl sinc last updat price target pt base
price-to-earnings multipl appli base case ep premium current
multipl line stock trade pre-medicar sell
new pt repres upsid last close price
bull/bear case valu previous bull case
multipl reflect turn premium current multipl
in-lin stock trade peak bear case multipl reflect
turn discount current multipl in-lin
stock trade trough last price cycl
estim chang updat estim account adventist health
revwork contract termin ablevet acquisit addit low-
margin contract termin possibl contempl pt remain
impli ep estim turn similar large-cap softwar
exhibit ms estim chang
estim lower revenu estim
million account million revenu
attribut adventist health revwork contract
termin well million addit contract
ration new estim million impli
y/i growth within guidanc
million oper margin estim remain
vs manag guidanc
estim lower revenu estim
million includ impact adventist
million low-margin contract termin
million flow partial off-set
million addit revenu ablevet acquisit
new estim million impli y/i
growth long-term guidanc
growth oper margin estim increas
reflect compani progress remov lower-
ablevet acquisiton low-margin
estim chang updat estim account compani new
guidanc well higher visibl revenu pt remain
exhibit ms estim chang inovalon
revenu decreas million million
reflect manag guidanc million ebitda
margin estim increas prior
reflect continu cost effici ep estim remain
unchang
revenu estim increas million
guidanc million impli growth
y/i increas ebitda estim million
million impli ebitda margin reflect
higher revenu estim partial off-set higher
expens compani continu hire train new
revenu ebitda estim increas
million million respect reflect chang
estim
calcul price target appli price-to-earnings multipl
base case ep multipl reflect turn discount
multipl discount in-lin stock
trade pre-medicar sell
bull case ep
bull case ep
bull case multipl reflect turn premium multipl
premium trade peak compani
see strong quarterli result yet get benefit tax
reform pbm transit exce goal result increment
enrol gain membership accumul continu base busi
pbm effici drive greater pbm profit penetr
base case well health plan enrol growth
base case ep
base case ep
base case multipl reflect turn discount multipl
discount in-lin stock trade pre-medicar sell
penetr upsid transit pbm live esrx run smooth result
better penetr within health plan book medicare/medicaid capit
bear case ep
bear case ep
bear case multipl reflect turn discount current multipl
discount trade trough last
industri price cycl failur execut pbm transit result lost profit
opportun enrol
consist grown
membership past sever year
across self-fund fulli insur
transit in-hous pharmaci
benefit busi pbm express script
result signific profit
opportun inclus save better
term current contract well
medicar advantag medicaid
greater pbm effici well
updat pbm transit
risk achiev price
sector multipl
pbm transit delay poor execut
result lower profit lost member
capit deploy delay
price pressur govern
commerci busi result margin
calcul price target appli price-to-earnings multipl
base case ep multipl reflect turn
discount multipl discount
vs discount pre-medicar sell reflect
increas competit dynam medicaid rfp bid process
consequ valuat pressur follow recent nc la medicaid
bull case ep
bull case ep
bull case multipl reflect turn discount multipl
in-lin averag discount last elect
year medicar advantag take exchang stabil see multipl
growth driver potenti headwind ceas materi due dc gridlock
medicar ramp significantli underli multipl close gap
medicaid group
base case ep
base case ep
base case multipl reflect turn discount multipl
trade discount medicar sell
howev view increas competit pressur medicaid rfp bid
process caus multipl compress rel
assum servic busi grow medicaid core execut medicar
advantag expans top exchang profit
bear ep
bear ep
bear case multipl reflect turn discount multipl
discount in-lin stock trade trough
last price cycl medicar advantag fail launch exchang margin
compress exchang becom headwind medicar advantag stall
loss core medicaid busi fide fail reach synergi target lose
robust suit servic
includ pbm capabl
servic well medicaid
growth medicar advantag focu
lower incom senior leverag current
medicaid footprint next growth
uncertainti futur exchang
medicaid drag
multipl think upsid medicar
advantag signific
pend acquisit wellcar give
greater scale greater exposur
medicar advantag pdp extend
top bottom line growth trajectori
announc expans new
texa unit state constitution
appeal
risk achiev price
sector multipl
deal wcg face signific regulatori
burden reach closur
exchang profit less expect
impact short term health plan
loss core medicaid contract
fide acquisit fail meet target
dcf-deriv pt wacc medium-term growth rate
price-to-earnings multipl appli bull case ep estim
revenu re-acceler high singl digit due faster-than-expect
uptak revenu cycl manag popul offer
newer offer ebitda margin expand beyond rang
price-to-earnings multipl appli base case ep estim
revenu grow mid-high single-digit ebitda margin
market leader global ehr
market account share us
market market alreadi
penetr greenfield opportun
hospit continu shift
spend area outsid core ehr
new revenu stream key
manag deliv long-term top-line
growth target revenu cycl
popul near-term
opportun market highli
competit translat slower
forecast growth
strateg growth initi
consum employ medicaid
provid upsid option requir
increment invest outsid
cut initi expand
oper margin near-to-mid term
sale growth everi bp growth
result accret earn
price-to-earnings multipl appli bear case ep estim
revenu growth deceler low-single-digit ebitda margin
risk achiev price
faster expect ramp va contract
revenu acceler non-cor
product popul health itwork
revenu cycl
expans hospit hcit budget
calcul price target appli price-to-earnings multipl
base case ep multipl reflect turn discount
current multipl vs current discount
discount in-lin stock trade pre-medicar
sell
bull case ep
bull case ep
bull case multipl reflect turn premium current multipl
premium in-lin stock trade peak
compani see strong quarterli result yet get benefit
tax reform esrx combin fuel growth bull case
combin creat power cross sell activ two compani
littl overlap addit combin drive higher expect cash
flow allow
flexibl deploy
base case ep
base case ep
base case multipl reflect turn discount current multipl
vs current discount discount in-lin stock
trade pre-medicar sell vertic integr come signific
cash flow gener acquisit esrx bring addit new
capabl specialti pharmaci increasingli larg spend beyond
vertic integr play combin expect gener signific cash
flow help compani de-lev month post close
bear case ep
bear case ep
bear case multipl reflect turn discount current multipl
discount in-lin stock trade trough
last price cycl vertic integr stall assum deal
reach vertic integr target oper two separ
busi unit synergi step back vertic integr
assum deterior core busi
follow acquisit pharmaci
benefit manag pbm express script
see increasingli vertic integr
player well posit meet market need
demonstr success drive
cost across core newli acquir
diversifi servic includ
intern exposur supplement
busi group disabl life segment
signific opportun
penetr remain compani
cross sell area alreadi
potenti abil upsel dental vision
ancillari servic help drive acceler
commerci enrol growth
risk achiev price
sector multipl
express script deal integr fail
signific deploy balanc
larg mco/pbm compet
pbm busi come on-line
commerci enrol growth
materi expect
combin aetna creat fulli
posit premier player
transform us healthcar
envis pivot role
reshap access health care leverag
exist real estat creat local
healthcar hub lead addit
combin aetna provid path
return earn growth
time align aetna
membership cost synergi
acceler pace debt paydown
de-lever underappreci market
front end store sale
retail rx store sale
month premium medic loss ratio
risk achiev price
plan buy new model
pt deriv use sotp analysi assign
ev/ebitda multipl retail ev/ebitda multipl
pharmaci servic price-to-earnings multipl health benefit
assumpt assum million net deal synergi
million enterpris modern cost save
assum combin ev/ebitda multipl repres
peak multipl compani see share gain strong
sell season valid integr caremark busi model
benefit assum price-to-earnings multipl base premium
 unitedhealthcar trade prior medicare-for-al sell
assign ev/ebitda multipl retail normal year
averag ev/ebitda multipl pharmaci servic express script
multipl one month prior acquisit announc price-to-earnings
multipl health benefit in-line averag
multipl rel prior medicar sell
current multipl trade modest
premium vs discount prior medicar sell base case
assum million net deal synergi million enterpris
assum combin ev/ebitda multipl repres
trough multipl initi /caremark integr period
health benefit assum price-to-earnings multipl trough
aetna multipl period structur concern regard manag care
model prior bear case assum expect deal synergi
enterpris modern initi materi also back
present valu estim cash flow associ potenti opioid
multiples-bas price target assum multipl
ebitda in-lin averag ev/ebitda multipl
softwar compani grow top-line ebitda margin
rang
bull case ebitda
bull case ebitda
ev/ebitda multipl appli bull case ebitda estim
million revenu acceler low-double-digit ebitda margin
improv rang
base case ebitda
base case ebitda
ev/ebitda multipl appli base case ebitda estim
million revenu growth remain mid-high singl digit
ebitda margin remain rang
bear case ebitda
bear case ebitda
ev/ebitda multipl appli bear case ebitda estim
million revenu growth declin low-singl digit ebitda margin
remain rang
inovalon provid cloud-bas
manag care organ provid
pharmaci life scienc organ
expect top-line organ growth
hsd-ldd rang contract
renew rate rang
acceler acv new client
revenu come subscript
increas visibl futur revenu stream
expect platform invest
oper effici continu drive
ebitda growth margin expans slightli
off-set invest sale
high net-debt ebitda leverag ratio
limit
renew upsel exist client
risk achiev price
calcul price target appli price-to-earnings multipl
base case ep base case price-to-earnings multipl
reflect turn premium multipl
premium in-lin stock trade pre-medicar
sell
bull case ep
bull case ep
bull case multipl reflect turn premium multipl
premium in-lin stock trade peak
compani see strong quarterli result yet get benefit
tax reform optum becom gold standard competit health plan
optum continu expand becom irreplac smaller plan
across pharmaci healthcar provid addit upsid growth
plan compliant octob execut order includ short term
base case ep
base case ep
base case multipl reflect turn premium multipl
premium in-lin stock trade pre-medicar sell
balanc growth leverag optum strength servic offer drive
double-digit ep growth healthcar busi integr model
continu gain steam
bear ep
bear ep
bear case multipl reflect turn discount multipl
discount in-lin stock trade trough
last price cycl competit advantag optum deterior offer
gain share mco want busi biggest competitor
advanc servic offer via optum
brand cover continuum healthcar
pharmaci benefit health outcom
core insur offer
well mani competitor
larg lead breadth offer
deep cultur root valu base care
well posit chang
us healthcar system addit
uncertainti base recent execut order
present potenti upsid new
product end csr subsidi
strong balanc sheet continu solid
cash gener give flexibl continu
detail guidanc dec
risk achiev price
sector multipl
optum growth slow competitor
becom reluct work
slower growth core growth area
medicar advantag commerci
medicaid focu servic
administr fee
sg expens net depreci
amort goodwill/intang
incom tax
benefit expens ratio premium
sg revenu
depreci revenu
amort revenu
servic
gener administr expens
amort intang
invest incom incom
goodwil intang impair
incom continu oper
 revenu
servic
tax rate hif
net incom continu oper
million
revenu
sale client servic
non- reconcili
cog revenu
sale client servic revenu
softwar develop revenu
gener administr revenu
cog revenu
sale client servic revenu
softwar develop revenu
gener administr revenu
revenu adjust transit client
medic cost benefit expens
sg
amort acquir intang asset net
special item incl addit amort esrx deal
incom continu oper
premium fee
incom tax
incom continu oper
good sold
gains-to-loss sale secur
sale
revenu
sale market
research develop
gener administr
depreci amort
ep dilut report gaap
ebit ebitda
depreci amort
sale market
product sold
depreci amort
invest incom
provis tax
earn non-controlling interest
incom continu oper
adjust incom cont op
invest incom
earn non-controlling interest
sg oper revenu
sg total revenu
amort oper revenu
